<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="19972">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02846896</url>
  </required_header>
  <id_info>
    <org_study_id>SwissPBC - SASL36</org_study_id>
    <nct_id>NCT02846896</nct_id>
  </id_info>
  <brief_title>The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland</brief_title>
  <official_title>The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Benedetta Terziroli, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondazione Epatocentro Ticino</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vifor Pharma</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Intercept Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Fondazione Epatocentro Ticino</source>
  <brief_summary>
    <textblock>
      PBC is a rare, autoimmune, cholestatic liver disease with genetic and environmental
      pathogenetic factors. Data about epidemiology of PBC in Switzerland are completely lacking.
      Epidemiology can be a powerful tool in yielding important clues as to burden and etiology of
      diseases. In addition, the investigators study will be the first one carried out in the
      country on PBC, and therefore will raise disease awareness and create a network.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 2015</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Prevalence of PBC in Switzerland</measure>
    <time_frame>from 1.1.2005 until 31.12.2015</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">501</enrollment>
  <condition>Primary Biliary Cirrhosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        PBC patients living in Switzerland
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  PBC patients living in Switzerland

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Fondazione Epatocentro Ticino</name>
      <address>
        <city>Lugano</city>
        <zip>6900</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 13, 2017</lastchanged_date>
  <firstreceived_date>July 25, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Fondazione Epatocentro Ticino</investigator_affiliation>
    <investigator_full_name>Benedetta Terziroli, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Liver Cirrhosis, Biliary</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
